1 – 4 Juillet 2020

ESMO World Congress on Gastrointestinal Cancer, 2020 Virtual

[Abstract P-80] A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)

View Poster

29 Mai – 2 Juin 2020

American Association of Clinical Oncology (ASCO)

[Abstract TPS4666] Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)

View Poster

Abstract #4617: ctDNA is prognostic and potentially predictive of eryaspase efficacy in patients with advanced pancreatic adenocarcinoma

View Poster

10 – 14 Decembre 2019

The San Antonio Breast Cancer Symposium

TRYbeCA-2: A Randomized Phase 2/3 Study of Eryaspase in Combination with Gemcitabine and Carboplatin Chemotherapy versus Chemotherapy Alone As First-Line Treatment in Patients with Metastatic or Locally Recurrent Triple-Negative Breast Cancer (NCT03674242)

  View Poster

3 – 4 Octobre 2019

CGRF, Lyon

CAPACITES DE LA PLATEFORME THERAPEUTIQUE ERYCAPS®

  View Poster

Profil protéomique de globules rouges soumis à un procédé d’encapsulation par dialyse hypotonique

  View Poster

2 – 4 Octobre 2019

CRCL, Lyon

DRUG-LOADED ERYTHROCYTES AS A NEW THERAPEUTIC OPTION IN ONCOLOGY

  View Poster

27 Septembre – 1er Octobre 2019

ESMO, Barcelona

TRYbeCA-2: A Randomized Phase 2/3 Study of Eryaspase in Combination with Gemcitabine and Carboplatin Chemotherapy versus Chemotherapy Alone As First-Line Treatment in Patients with Metastatic or Locally Recurrent Triple-Negative Breast Cancer (NCT03674242)

  View Poster

6 – 9 Septembre 2019

AACR pancreatic meeting, Boston

TRYbeCA-1: A Randomized, Phase 3 Study of Eryaspase in CombinaBon with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in PaBents with PancreaBc Adenocarcinoma (NCT03665441)

  View Poster

4 Juillet 2019

ESMO World Congress on Gastrointestinal Cancer 2019

Abstract P-098: Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)

  Voir le Poster

1er Avril 2019

AACR – American Association for Cancer Research

Erymethionase (methionine-γ-lyase encapsulated into red blood cells)
potentiates anti-PD1 therapy in TNBC-like syngeneic mouse model

  Voir le Poster

11 Mars 2019

ERCS European Red Cell Research Society 22nd Meeting

Profilage protéomique complet des érythrocytes à la suite d’un procédé hypotonique d’encapsulation de médicaments basé sur la dialyse

  Voir le Poster

17-19 Janvier 2019

Gastrointestinal Cancers Symposium (ASCO-GI)

Abstract TPS471: Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441).

  Voir le Poster

14-17 Juin 2018

European Hematology Association (EHA) Congress

Preclinical Demonstration of Intracellular Activity of Asparaginase Encapsulated in Red Blood Cells Both in the Absence and in the Presence of Neutralizing Anti-Asparaginase Antibodies

Quand : Vendredi 15 Juin 2018 / 17h30 – 19h00

  Voir le Poster

A Phase 2b of Eryaspase in Combination with Low-Dose Cytarabine as First-Line Therapy in Elderly Patients with Acute Myeloid Leukemia (ENFORCE – NCT01810705)

Quand : Samedi 16 Juin 2018 / 17h30 – 19h00

  Voir le Poster

Venous Thromboembolism in Patients with Acute Lymphoblastic Leukemia (ALL) Treated with Eryaspase (L-Asparaginase Encapsulated in Red Blood Cells)

  Voir l’abstract

1-5 Juin 2018

American Society of Cancer Oncology (ASCO)

Pharmacodynamic Characterization of eryaspase (L-asparaginase Encapsulated in Red Blood Cells) in Combination with Chemotherapy in a Phase 2/3 Trial in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517).

Quand : 4 Juin 2018

  Voir le Poster

14-18 avril 2018

American Association for Cancer Research (AACR)

A Phase 1 Study Of Eryaspase (L-Asparaginase Encapsulated In Red Blood Cells) In Combination With Induction And Consolidation Chemotherapy For Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) (NCT01910428)

Quand : 15 avril 2018

Voir le Poster

Enzymatic combination investigation in cancer therapy

Quand : 18 avril 2018

Voir le Poster

8-12 septembre 2017

European Society for Medical Oncology (ESMO)

A Phase 2b of eryaspase in combination with gemcitabine or FOLFOX as second-line therapy in patients with metastatic pancreatic adenocarcinoma (NCT02195180)

Quand : 8-11 septembre 2017

  Voir le Poster

5-8 septembre 2017

13th International Congress of Inborn Errors of Metabolism (ICIEM)

Eryminase, Arginine Deiminase-Encapsulated in Red Blood Cells Effectively Lower Blood Arginine Levels in a Mouse Model of Inducible Hyperargininemia

Quand : 6 septembre 2017/ 5:30-8:00PM BRT

  Voir le Poster

Erymethionase, Methioninase Entrapped in Red Blood Cells: an innovative treatment approach for classical homocystinuria

Quand : 6 septembre 2017/ 5:30-8:00PM BRT

  Voir le Poster

 

1-5 avril 2017

American Association for Cancer Research (AACR) Annual Meeting

Use of methionine gamma-lyase-loaded erythrocytes to induce effective methionine depletion of cancer therapy

Quand : 3 avril 2017/1:00-5:00 PM EDT

  Voir le Poster

19-21 janvier 2017

2017 Gastrointestinal Cancers Symposium (ASCO GI)
Methionine gamma-lyase-encapsulated into red blood cells (ERY-MET) shows profound antitumor activity in gastric carcinoma

Quand : 19 janvier 2017/12:30-2PM PST, 5:30-7PM PST

  Voir le Poster
Menu